Market closed· · CHF · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Investing.com -- European medtech has had another bruising year, with only Demant and Sonova outperforming the Stoxx 600 in 2026 as the sector’s once-premium valuation continues to de-rate.
IART vs. SONVY: Which Stock Is the Better Value Option?
STAFA, SWITZERLAND - June 16, 2026 (NEWMEDIAWIRE) - Sonova Holding AG (SWX: SOON), the leading provider of innovative hearing care solutions, announces the results of its 41st Annual General Meeting (AGM), held today. The shareholders approved al...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.